Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: GlobalData
Provider: Plunkett Research, Ltd.
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sernova Corp Completes Non-Brokered Private Placement

Tuesday, 19 Feb 2013 06:00am EST 

Sernova Corp announced that further to its news release dated January 21, 2013, it has now closed its non-brokered private placement consisting of 10,000,000 units (the Units) at a price of $0.20 per Unit for gross proceeds of $2,000,000 (the Offering). Net proceeds from the offering will be utilized in the advancement of Sernova's clinical development program of its Cell Pouch(TM) for the treatment of diabetes, new product initiatives and general corporate purposes. Each Unit consists of one common share and one common share purchase warrant (a Warrant), with each Warrant entitling the holder thereof to purchase one common share of the Company (a Warrant Share) for a period of 36 months from the closing of the Offering (the Exercise Period) at a price of $0.35 per Warrant Share for the first 24 months of the Exercise Period and at a price of $0.40 per Warrant Share for the last 12 months of the Exercise Period. All securities issued pursuant to the Offering are subject to a four month hold period expiring on June 15, 2013. 

Company Quote

-0.0050 -3.13%
24 Dec 2014